David J. Tweardy - 15 Apr 2025 SCHEDULE 13G Report for TVARDI THERAPEUTICS, INC. Common Stock, par value $0.001 per share (CARA)

Filing Manager
David J. Tweardy
Reporting Manager
David J. Tweardy
Security
TVARDI THERAPEUTICS, INC. Common Stock, par value $0.001 per share
Symbol
CARA
Shares outstanding
9,319,971 shares
Disclosed Ownership
652,398 shares
Ownership
7%
Form type
SCHEDULE 13G
Filing time
02 May 2025, 16:21:31 UTC
Date of event
15 Apr 2025
SEC
View on sec.gov

Quoteable Key Fact

"David J. Tweardy disclosed 7% ownership in TVARDI THERAPEUTICS, INC. Common Stock, par value $0.001 per share (CARA) on 15 Apr 2025."

Quick Takeaways

  • David J. Tweardy filed SCHEDULE 13G for TVARDI THERAPEUTICS, INC. Common Stock, par value $0.001 per share (CARA).
  • Disclosed ownership: 7%.
  • Date of event: 15 Apr 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 02 May 2025, 16:21.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
David J. Tweardy 7% 652,398 652,398 0 /s/ David J. Tweardy David J. Tweardy
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .